The British Psychological Society has released evidence-based recommendations for health professionals managing the psychological health of people with Huntington’s disease…
Articles by Marta Figueiredo, PhD
Higher-than-normal levels of mu-opioid receptor 1 (MOR1) in the striatum — a brain region particularly affected in Huntington’s disease…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
Prilenia Therapeutics, in partnership with the Huntington Study Group (HSG), has launched the Phase 3 PROOF-HDÂ clinical trial to…
Behavioral changes due to early onset Huntington’s disease and problems with school, and social and family life are common,  particularly…
Huntington’s disease alters nerve cell development in the cortex — a brain region largely affected in people with…
Antidopaminergic medications are associated with lesser chorea and irritability in people with Huntington’s disease, but they may worsen their cognitive…
Vaccinex’s experimental therapy pepinemab (VX15/2503) improves brain metabolism, halts its atrophy, and eases motor and cognitive symptoms…
Researchers have identified three new small molecules that significantly reduce the formation of toxic aggregates of mutant huntingtin — the…
The mini pig model of Huntington’s disease not only has a similar brain anatomy to humans, but also shows…